Eriko Suzuki

3.7k total citations
108 papers, 2.8k citations indexed

About

Eriko Suzuki is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Eriko Suzuki has authored 108 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 32 papers in Pulmonary and Respiratory Medicine and 24 papers in Oncology. Recurrent topics in Eriko Suzuki's work include Lung Cancer Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (15 papers) and Cardiac Imaging and Diagnostics (9 papers). Eriko Suzuki is often cited by papers focused on Lung Cancer Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (15 papers) and Cardiac Imaging and Diagnostics (9 papers). Eriko Suzuki collaborates with scholars based in Japan, United States and Netherlands. Eriko Suzuki's co-authors include Yoshihiro Kobayashi, Motoki Yano, Yoshitaka Fujii, Katsuhiko Endo, Hiroshi Haneda, Hidefumi Sasaki, Haruhiro Yukiue, Osamu Kawano, Shigeaki Kato and Saya Ito and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Eriko Suzuki

106 papers receiving 2.7k citations

Peers

Eriko Suzuki
Comparison fields: 5 of 119
  • Molecular Biology 1.3k
  • Pulmonary and Respiratory Medicine 875
  • Oncology 650
  • Cancer Research 348
  • Immunology 223
Replace Yong Wen with:
Yong Wen United States
Michael L. Lu United States
Richard Clarkson United Kingdom
Gary R. Fanger United States
Judith H. Harmey Ireland
Wen‐Jye Lin Taiwan
Panayiotis A. Theodoropoulos Greece
Susan S. Leong United States
Tomoki Yamatsuji Japan
Nader Rahimi United States
Yong Wen United States View profile →
Citations per field, relative to Eriko Suzuki
Eriko Suzuki · 1×
Citations per year, relative to Eriko Suzuki
Eriko Suzuki · 1×

Countries citing papers authored by Eriko Suzuki

Since Specialization
Citations

This map shows the geographic impact of Eriko Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Suzuki more than expected).

Fields of papers citing papers by Eriko Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eriko Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Suzuki. The network helps show where Eriko Suzuki may publish in the future.

Co-authorship network of co-authors of Eriko Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Eriko Suzuki. A scholar is included among the top collaborators of Eriko Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eriko Suzuki. Eriko Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 2
3 14
4 2
5 18
6 4
7 1
8 3
9 3
10 1
11 290
12
Sensitization of B-NHL resistant tumor cells overexpressing Bcl-xL to TRAIL-induced apoptosis by the novel proteasome inhibitor Salinosporamide A (NPI-0052)
1
13
Rituximab sensitizes resistant B-NHL cell lines to the proteasome inhibitor NPI-0052-induced apoptosis.
1
14 213
15 73
16 55
17 33
18 128
19 40
20 17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026